In-Depth Insights into Actual Search Behavior Related to Pharmaceuticals and AI-Based Prompts

Rote Liste Analytics

AI-powered research has long been part of everyday pharmaceutical practice and has a measurable impact on the use of professional and consumer information.

Here’s an example: In one week in December 2025 , OpenAI ChatGPT alone accounted for 16% of all views of professional information published through our channels and the trend is clearly on the rise.

A significant portion of information searches - by both healthcare professionals and patients is increasingly shifting to AI systems. The acceptance of chatbots for medical and pharmaceutical research is growing significantly - and with it, the importance of structured, up-to-date, and reliable sources.

For pharmaceutical companies, this means that visibility no longer comes exclusively from direct website traffic, but also from AI-powered queries. It is crucial that prescribing and patient information be available at all times in their current, regulatory-approved versions - so that AI systems can use valid and quality-assured content.

With our portals such as Rote-Liste.de, Fachinfo.de, and Gebrauchsinformation4-0.de, we are a relevant source for this new form of research - including for ChatGPT and other AI applications.

Rote Liste Analytics, our exclusive analysis and reporting tool, provides transparency into actual search behavior related to drug information and its digital visibility. You’ll gain in-depth insights into demand trends, usage patterns, and market comparisons - serving as a reliable foundation for data-driven decisions.

If you’d like to learn what insights Rote Liste Analytics already offers today and how your company can gain access, please feel free to contact us!

 

Contact Us